CURRENT MEDICATIONS OVERVIEW,,
MEDICATION,GENE(S),PRESCRIBING CONSIDERATIONS BASED ON myDNA TEST
"Atorvastatin","CYP3A4SLCO1B1","Minor – result should be considered as may affect medicationresponse"
"Escitalopram(Lexapro)",CYP2C19,"Minor – result should be considered as may affect medicationresponse"
"Glibenclamide",CYP2C9,"Minor – result should be considered as may affect medicationresponse"
MEDICATIONS THAT DO NOT HAVE PRESCRIBING CONSIDERATIONS BASED ON myDNA TEST,,
"ezetimibe, metformin, levothyroxine sodium (Levothyroxine Sodium For Injection), valsartan, insulin (Lantus)",,
MEDICATIONS WITH MAJOR PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
Anticoagulants,Acenocoumarol,"VKORC1CYP2C9","Significantly increasedacenocoumarol sensitivity",DPWG
"",Warfarin,"VKORC1CYP2C9","Significantly increased warfarinsensitivity",FDA2
Antiepileptics,Phenytoin,CYP2C9,Adverse effects,CPIC3
Antiplatelet drugs,Clopidogrel,CYP2C19,Reduced / inadequate response,CPIC4
Statins,Simvastatin,"SLCO1B1CYP3A4",Adverse effects,CPIC5
MEDICATIONS WITH MINOR PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
"Angiotensin receptorblockers",Irbesartan,CYP2C9,"Increased therapeutic and/oradverse effects",-
"",Losartan,CYP2C9,Reduced / inadequate response,-
"Antidepressants -other",Mirtazapine,"CYP2D6CYP1A2",Reduced / inadequate response,-
"",Moclobemide,CYP2C19,Adverse effects,-
"Antidepressants -serotoninnoradrenalinereuptake inhibitors",Duloxetine,"CYP2D6CYP1A2",Reduced / inadequate response,-
"Antidepressants -SSRIs",Citalopram,CYP2C19,Adverse effects,CPIC1
"",Escitalopram,CYP2C19,Adverse effects,CPIC1
"",Fluoxetine,"CYP2D6CYP2C9",Altered response,-
"",Sertraline,CYP2C19,Adverse effects,CPIC1
"Antidepressants -tricyclicantidepressants",Amitriptyline,"CYP2D6CYP2C19",Altered response,CPIC6
"",Clomipramine,"CYP2D6CYP2C19",Altered response,CPIC6
"",Doxepin,"CYP2D6CYP2C19",Altered response,CPIC6
"",Imipramine,"CYP2D6CYP2C19",Altered response,CPIC6
Antidiabetics,Gliclazide,"CYP2C9CYP2C19","Increased therapeutic and/oradverse effects",-
"",Glimepiride,CYP2C9,"Increased therapeutic and/oradverse effects",-
"",Glyburide,CYP2C9,"Increased therapeutic and/oradverse effects",-
Antifungals - Azoles,Voriconazole,CYP2C19,"Increased therapeutic and/oradverse effects",CPIC7
Antipsychotics,Clozapine,CYP1A2,Reduced / inadequate response,-
"",Olanzapine,CYP1A2,Reduced / inadequate response,-
Benzodiazepines,Clobazam,CYP2C19,Adverse effects,-
"",Diazepam,CYP2C19,Adverse effects,-
Beta blockers,Propranolol,"CYP2D6CYP1A2",Altered response,-
Hypnotics,Melatonin,CYP1A2,Reduced / inadequate response,-
Miscellaneous,Cyclophosphamide,CYP2C19,Reduced / inadequate response,-
"",Naltrexone,OPRM1,"Associated with reducedresponse to naltrexone",
"",Proguanil,CYP2C19,Reduced / inadequate response,-
NSAIDs,Celecoxib,CYP2C9,"Increased therapeutic and/oradverse effects",-
"",Diclofenac,CYP2C9,Adverse effects,-
"",Flurbiprofen,CYP2C9,Adverse effects,-
"",Ibuprofen,CYP2C9,Adverse effects,-
"",Indomethacin,CYP2C9,Adverse effects,-
"",Mefenamic Acid,CYP2C9,Adverse effects,-
"",Meloxicam,CYP2C9,Adverse effects,-
"",Piroxicam,CYP2C9,Adverse effects,-
Opioid Analgesics,Morphine,OPRM1,"Associated with increasedtherapeutic and/or adverseeffects to morphine",-
MEDICATIONS WITH MINOR PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
"Proton pumpinhibitors",Dexlansoprazole,CYP2C19,"Increased therapeutic and/oradverse effects",FDA8
"",Esomeprazole,CYP2C19,"Increased therapeutic and/oradverse effects",-
"",Lansoprazole,CYP2C19,"Increased therapeutic and/oradverse effects",-
"",Omeprazole,CYP2C19,"Increased therapeutic and/oradverse effects",-
"",Pantoprazole,CYP2C19,"Increased therapeutic and/oradverse effects",-
"",Rabeprazole,CYP2C19,"Increased therapeutic and/oradverse effects",-
Statins,Atorvastatin,"SLCO1B1CYP3A4",Adverse effects,-
Fluvastatin,"SLCO1B1CYP2C9","Increased therapeutic and/oradverse effects",-,
MEDICATIONS WITH USUAL PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
"ADHD -miscellaneous agents",Atomoxetine,CYP2D6,"No altered effect predicted bygenotype",-
Antiarrhythmics,Flecainide,CYP2D6,"No altered effect predicted bygenotype",-
"",Propafenone,CYP2D6,"No altered effect predicted bygenotype",-
"Anticholinergics(genitourinary)",Darifenacin,CYP2D6,"No altered effect predicted bygenotype",-
"",Fesoterodine,CYP2D6,"No altered effect predicted bygenotype",-
"",Tolterodine,CYP2D6,"No altered effect predicted bygenotype",-
Anticholinesterases,Donepezil,CYP2D6,"No altered effect predicted bygenotype",-
"",Galantamine,CYP2D6,"No altered effect predicted bygenotype",-
"Antidepressants -other",Vortioxetine,CYP2D6,"No altered effect predicted bygenotype",-
"Antidepressants -serotoninnoradrenalinereuptake inhibitors",Venlafaxine,CYP2D6,"No altered effect predicted bygenotype",DPWG9
"Antidepressants -SSRIs",Fluvoxamine,"CYP2D6CYP1A2","No altered effect predicted bygenotype",CPIC1
"",Paroxetine,CYP2D6,"No altered effect predicted bygenotype",CPIC1
"Antidepressants -tricyclicantidepressants",Desipramine,CYP2D6,"No altered effect predicted bygenotype",CPIC6
"",Nortriptyline,CYP2D6,"No altered effect predicted bygenotype",CPIC6
Antiemetics,Metoclopramide,CYP2D6,"No altered effect predicted bygenotype",-
MEDICATIONS WITH USUAL PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
"",Ondansetron,CYP2D6,"No altered effect predicted bygenotype",CPIC10
Antihistamines,Chlorpheniramine,CYP2D6,"No altered effect predicted bygenotype",-
"",Dexchlorpheniramine,CYP2D6,"No altered effect predicted bygenotype",-
"",Promethazine,CYP2D6,"No altered effect predicted bygenotype",-
Antipsychotics,Aripiprazole,CYP2D6,"No altered effect predicted bygenotype",-
"",Brexpiprazole,CYP2D6,"No altered effect predicted bygenotype",-
"",Chlorpromazine,CYP2D6,"No altered effect predicted bygenotype",-
"",Haloperidol,CYP2D6,"No altered effect predicted bygenotype",-
"",Pimozide,CYP2D6,"No altered effect predicted bygenotype",
"",Quetiapine,CYP3A4,"No altered effect predicted bygenotype",-
"",Risperidone,CYP2D6,"No altered effect predicted bygenotype",-
"",Zuclopenthixol,CYP2D6,"No altered effect predicted bygenotype",-
Antitussives,Dextromethorphan,CYP2D6,"No altered effect predicted bygenotype",-
Beta blockers,Carvedilol,CYP2D6,"No altered effect predicted bygenotype",-
"",Metoprolol,CYP2D6,"No altered effect predicted bygenotype",-
"",Nebivolol,CYP2D6,"No altered effect predicted bygenotype",-
Calcineurin inhibitors,Tacrolimus,CYP3A5,"No altered effect predicted bygenotype",CPIC11
"Glaucoma - ocularpreparations",Timolol,CYP2D6,"No altered effect predicted bygenotype",-
"Immunomodulatorsand antineoplastics",Tamoxifen,CYP2D6,"No altered effect predicted bygenotype",CPIC12
Miscellaneous,Atazanavir,CYP3A5,"No altered effect predicted bygenotype",-
"",Eliglustat,CYP2D6,"No altered effect predicted bygenotype",TGA13
Neurological drugs,Tetrabenazine,CYP2D6,"No altered effect predicted bygenotype",FDA14
Opioid Analgesics,Codeine,"CYP2D6OPRM1","Associated with increasedsensitivity to codeine",CPIC15
"",Hydrocodone,CYP2D6,"No altered effect predicted bygenotype",
"",Oxycodone,CYP2D6,"No altered effect predicted bygenotype",-
"",Tramadol,CYP2D6,"No altered effect predicted bygenotype",-
Psychostimulants,Dextroamphetamine,CYP2D6,"No altered effect predicted bygenotype",-
MEDICATIONS WITH USUAL PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
"",Lisdexamfetamine,CYP2D6,"No altered effect predicted bygenotype",-
Statins,Pravastatin,SLCO1B1,"No altered effect predicted bygenotype",-
Rosuvastatin,SLCO1B1,"No altered effect predicted bygenotype",-,
